Literature DB >> 2026461

Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain.

E W Petersdorf1, A G Smith, E M Mickelson, P J Martin, J A Hansen.   

Abstract

We have studied DRB1 sequence polymorphisms associated with DR4 subtypes using DR4-specific DNA amplification and sequence-specific oligonucleotide probe (SSOP) hybridization. The 5' amplification primer was designed to hybridize with a unique sequence in the first hypervariable region (HVR) of the DRB1 second exon of all known DR4 alleles; the 3' primer was designed to hybridize with an intron sequence common to all DRB1 The specificity of the amplification step was demonstrated by double-blind testing of 105 selected DNA samples. Prospective SSOP typing of DR4 alleles was performed in 104 unrelated individuals known to be DR4-positive, including 13 who were DR4-homozygous. A DRB1 subtype corresponding with the previously defined DR4-associated specificities Dw4, Dw10, Dw13.1, Dw13.2, Dw14.1, Dw14.2, Dw15, and DwKT2 could be assigned for each of the 117 DR4 haplotypes tested. In most cases, DR4-homozygous, DRB1-heterozygous individuals could be genotyped with the panel of probes. In the course of our analysis, we identified two new DR4-related alleles, DRB1*04.CB (DRB1*0410)1 and DRB1*04.EC (DRB1*, 0411)2 which were recognized by their novel hybridization patterns. The DRB1 second exon sequence of DRB1*04.CB is identical to DRB1*0405 except at codon 86 where GTG encodes valine instead of GGT encoding glycine. DRB1*04.EC is identical to DRB1*04.CB except at codon 74 where GAG encodes glutamic acid instead of GCG encoding alanine. Our results provide further evidence that SSOP hybridization is the most effective approach available for subtyping DR4 haplotypes and identifying unrecognized variants. A similar approach should be equally informative for subtyping other DR alleles.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026461     DOI: 10.1007/bf00230505

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  32 in total

1.  Further DNA sequence microheterogeneity of the HLA-DR4/Dw13 haplotype group: importance of amino acid position 86 of the DR beta 1 chain for T-cell recognition.

Authors:  B Lang; C Navarrete; P R LoGalbo; G T Nepom; J Silver; R J Winchester; P K Gregersen
Journal:  Hum Immunol       Date:  1990-04       Impact factor: 2.850

Review 2.  Nomenclature for factors of the HLA system, 1989.

Authors:  J G Bodmer; S G Marsh; E Albert
Journal:  Immunol Today       Date:  1990-01

3.  Heterogeneity of HLA-DR4 in Greeks including a unique DR4-DQw2 association.

Authors:  J Awad; W Ollier; S Cutbush; C Papasteriadis; A Gupta; D Carthy; D McCloskey; C J Brown; K Boki; G Fostizopoulos
Journal:  Tissue Antigens       Date:  1990-01

4.  Allelic variation in the DR subregion of the human major histocompatibility complex.

Authors:  J I Bell; D Denney; L Foster; T Belt; J A Todd; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

5.  The HLA system in Inupiat and Central Yupik Alaskan Eskimos.

Authors:  J A Hansen; A P Lanier; B Nisperos; E Mickelson; S Dahlberg
Journal:  Hum Immunol       Date:  1986-08       Impact factor: 2.850

6.  A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.

Authors:  J H Brown; T Jardetzky; M A Saper; B Samraoui; P J Bjorkman; D C Wiley
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

7.  Base composition-independent hybridization in tetramethylammonium chloride: a method for oligonucleotide screening of highly complex gene libraries.

Authors:  W I Wood; J Gitschier; L A Lasky; R M Lawn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

8.  Microheterogeneity of HLA-DR4 haplotypes: DNA sequence analysis of LD"KT2" and LD"TAS" haplotypes.

Authors:  P K Gregersen; S M Goyert; Q L Song; J Silver
Journal:  Hum Immunol       Date:  1987-08       Impact factor: 2.850

9.  Five HLA-D clusters associated with HLA-DR4.

Authors:  N L Reinsmoen; F H Bach
Journal:  Hum Immunol       Date:  1982-06       Impact factor: 2.850

10.  HLA-DR2 and DR4 further defined by two new HLA-D specificities (HTC) derived from Israeli Jewish donors: comparative study in Caucasian, Korean, Eskimo and Israeli populations.

Authors:  E Mickelson; C Brautbar; B Nisperos; N Cohen; A Amar; S J Kim; A Lanier; J A Hansen
Journal:  Tissue Antigens       Date:  1984-09
View more
  12 in total

1.  Long-range multilocus haplotype phasing of the MHC.

Authors:  Zhen Guo; Leroy Hood; Mari Malkki; Effie W Petersdorf
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

Review 2.  HLA class I nucleotide sequences, 1991.

Authors:  J Zemmour; P Parham
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  A novel HLA-DR4 haplotype generated by a rare recombinational event between DRB1 and DQA1 loci.

Authors:  C Carcassi; R Giorda; M Trucco; L Contu
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

4.  Nomenclature for factors of the HLA system, 1990. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

5.  HLA class II diversity in Australian aborigines: unusual HLA-DRB1 alleles.

Authors:  X Gao; A Veale; S W Serjeantson
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category.

Authors:  Ann Woolfrey; Stephanie J Lee; Ted A Gooley; Mari Malkki; Paul J Martin; John M Pagel; John A Hansen; Effie Petersdorf
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-04       Impact factor: 5.742

7.  Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.

Authors:  Jean E Sanders; Ho Joon Im; Paul A Hoffmeister; Ted A Gooley; Ann E Woolfrey; Paul A Carpenter; Robert G Andrews; Eileen M Bryant; Frederick R Appelbaum
Journal:  Blood       Date:  2005-01-06       Impact factor: 22.113

8.  Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.

Authors:  Hirohisa Nakamae; Barry E Storer; Rainer Storb; Jan Storek; Thomas R Chauncey; Michael A Pulsipher; Finn B Petersen; James C Wade; Michael B Maris; Benedetto Bruno; Jens Panse; Effie Petersdorf; Ann Woolfrey; David G Maloney; Brenda M Sandmaier
Journal:  Biol Blood Marrow Transplant       Date:  2009-11-10       Impact factor: 5.742

9.  Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.

Authors:  S L Topalian; L Rivoltini; M Mancini; N R Markus; P F Robbins; Y Kawakami; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

10.  HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410.

Authors:  Y Shindo; H Inoko; T Yamamoto; S Ohno
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.